Intravenous N-acetylcysteine is associated with fewer of the adverse effects seen with the oral preparation, such as nausea, vomiting, abdominal pain, diarrhea and rash, but it carries a higher risk of anaphylactoid reactions.9 When patients present relatively late after ingestion, oral N-acetylcysteine protocols provide a higher dose given over a longer period, which may be an advantage.2 , 10 However, the gastrointestinal adverse effects associated with oral therapy are a substantial disadvantage, notably if this results in a longer time for drug absorption and hence a longer time to reach therapeutic effect.2 Since the introduction and adoption of routine use of N-acetylcysteine therapy, the mortality rate in acetaminophen overdose has declined from 3% to 0.7%.11 Prevention of overdose and medication errors in children This report highlights the issue of accurate dosing in pediatrics

The aqueous extract of Christs thorn ( Ziziphus spina-christi ) seed modulates hyperlipidemia in hypercholesterolemic male rat
"How Do I Know It's Safe?" When administered in-office by licensed medical professionals following established protocols, BPC-157 is generally very well-tolerated
I am having menopausal symptoms and was searching for a supplement to take
Farxiga: Key differences Rybelsus vs
"Your body is a complex, interconnected system